Professional Documents
Culture Documents
Printed by: Dang Van Vu Official Date: Official as of 01-Dec-2017 Document Type: USP @2023 USPC
Do Not Distribute DOI Ref: 0h0mi DOI: https://doi.org/10.31003/USPNF_M70160_01_01
1
Suitability requirements
Promethazine Hydrochloride Oral Resolution: NLT 5.0 between promethazine and
Solution promethazine related compound B peaks, System
suitability solution
DEFINITION Tailing factor: NMT 2.0, Standard solution
Promethazine Hydrochloride Oral Solution contains NLT Relative standard deviation: NMT 1.0%, Standard
90.0% and NMT 110.0% of the labeled amount of solution
promethazine hydrochloride (C17H20N2S · HCl). Analysis
[NOTE—Throughout the following procedures, protect the Samples: Standard solution and Sample solution
samples, the Reference Standards, and the solutions Calculate the percentage of the labeled amount of
containing them, by conducting the procedures without promethazine hydrochloride (C17H20N2S · HCl) in the
delay, under subdued light or using low-actinic portion of Oral Solution taken:
glassware.]
Result = (rU/rS) × (CS/CU) × 100
IDENTIFICATION
• A. The retention time of the major peak of the Sample rU = peak response from the Sample solution
solution corresponds to that of the Standard solution, as rS = peak response from the Standard solution
obtained in the Assay.
CS = concentration of USP Promethazine
• B. The UV spectrum of the major peak of the Sample
Hydrochloride RS in the Standard solution
solution corresponds to that of the Standard solution, as
(mg/mL)
obtained in the Assay.
CU = nominal concentration of promethazine
ASSAY hydrochloride in the Sample solution (mg/mL)
al
• PROCEDURE
Buffer: 3.7 g/L of ammonium acetate in water Acceptance criteria: 90.0%–110.0%
Solution A: Acetonitrile and Buffer (30:70) IMPURITIES
Solution B: Acetonitrile • ORGANIC IMPURITIES
Mobile phase: See Table 1. ci Buffer, Solution A, Solution B, Mobile phase, Diluent, and
Chromatographic system: Proceed as directed in the
Table 1
Assay.
Time Solution A Solution B Standard solution: 1.0 µg/mL each of USP Promethazine
(min) (%) (%)
Hydrochloride RS and USP Promethazine Related
0 100 0 Compound B RS in Diluent
ffi
Sample solution: Nominally 500 µg/mL of promethazine
10 60 40
hydrochloride from a volume of Oral Solution in Diluent.
18 60 40 Centrifuge for 10 min and use the supernatant.
[NOTE—Sonication may be used in the preparation of the
18.1 100 0
Standard solution and the Sample solution.]
25 100 0 System suitability
O
https://online.uspnf.com/uspnf/document/1_GUID-BF7F4422-A018-49C0-B9EB-65773E07DDF7_1_en-US 1/2
www.webofpharma.com
Printed on: Wed Feb 08 2023, 11:48:34 PM(EST) Status: Currently Official on 09-Feb-2023 DocId: GUID-BF7F4422-A018-49C0-B9EB-65773E07DDF7_1_en-US
Printed by: Dang Van Vu Official Date: Official as of 01-Dec-2017 Document Type: USP @2023 USPC
Do Not Distribute DOI Ref: 0h0mi DOI: https://doi.org/10.31003/USPNF_M70160_01_01
2
al
ci
ffi
O
https://online.uspnf.com/uspnf/document/1_GUID-BF7F4422-A018-49C0-B9EB-65773E07DDF7_1_en-US 2/2
www.webofpharma.com